Irena Ljungcrantz
Malmoe, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Deletion of PKM2 in Macrophages Promotes Stabilization but Not Regression of Atherosclerotic Plaques.
Journal: Circulation research
Published: April 15, 2026
Deletion of PKM2 in Macrophages Promotes Stabilization but Not Regression of Atherosclerotic Plaques.
Journal: Circulation research
Published: April 15, 2026
Impaired SARS-CoV-2 vaccine responsiveness is not associated with subclinical atherosclerosis or cardiovascular disease.
Journal: European heart journal open
Published: July 01, 2025
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction.
Journal: Critical care (London, England)
Published: July 03, 2023
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation.
Journal: Cardiovascular research
Published: March 14, 2023
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.
Journal: Vascular pharmacology
Published: August 19, 2020
Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice.
Journal: Circulation
Published: May 29, 2019
Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease.
Journal: Diabetes & vascular disease research
Published: December 22, 2018
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.
Journal: Vascular pharmacology
Published: June 20, 2018
Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells.
Journal: Human immunology
Published: December 04, 2017
Last Updated: 09/26/2026